Close this window

Transaction in Own Shares

08/18/2026
RNS Number : 9379Q
Fevertree Drinks PLC
18 August 2026
 

18th August 2026                   

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 10th August to 14th August 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

10 August 2026

XLON

880.5027

38,645

856.5000

893.0000

10 August 2026

AIMX

865.4394

12,375

861.5000

868.0000

11 August 2026

XLON

857.2866

18,347

851.5000

874.5000

11 August 2026

AIMX

858.7642

34,009

857.0000

859.0000

12 August 2026

XLON

857.9725

16,383

850.0000

864.0000

12 August 2026

AIMX

859.0000

15,380

859.0000

859.0000

13 August 2026

XLON

866.8592

12,239

855.0000

872.5000

13 August 2026

AIMX

870.5000

5,000

870.5000

870.5000

14 August 2026

XLON

869.8788

21,141

862.5000

875.5000

14 August 2026

AIMX

869.7000

26,000

869.7000

869.7000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/9379Q_1-2026-8-17.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVDLBFQVLFBBL

Multimedia Files:

Close this window